Pre-IPO · BiotechOricell Therapeutics: Pre-IPODevelops next-generation cell therapies for oncology and immunologyPublished Oct 4, 2026By RoundOS Funding deskFunding historyApr 9, 2026Pre-IPO · This round$110MJan 12, 2026Series C1$70MSourcesprnewswire.com↗
Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.UndisclosedSeed · Oct 23, 2026
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200MPrivate financing · Oct 23, 2026
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237MSeries E · Oct 23, 2026
Warp SciencesWarp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.$215MSeries A · Oct 22, 2026